Literature DB >> 16076536

Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells.

Chittima Managit1, Shigeru Kawakami, Fumiyoshi Yamashita, Mitsuru Hashida.   

Abstract

Galactosylated (Gal) emulsions containing various molar ratios of cholesten-5-yloxy-N-(4-((1-imino-2-D-thiogalactosylethyl)amino)butyl)formamide (Gal-C4-Chol) as a ligand for asialoglycoprotein receptors were prepared to study the effect of the galactose content of Gal-emulsions labeled with [3H]cholesteryl hexadecyl ether on their targeted delivery to hepatocytes. The uptake characteristics of Gal-emulsions having Gal-C4-Chol of 1, 3, 4, 6, and 9 mol% were evaluated in HepG2 cells which possess asialoglycoprotein receptors and NIH3T3 cells which are lack of asialoglycoprotein receptors. The uptake and internalization by HepG2 cells was enhanced by the addition of Gal-C4-Chol to the Gal-emulsions whereas the uptake of Gal-emulsions by NIH3T3 cells was not much and was comparable with that of bare-emulsions. In the presence of excess Gal-BSA, the uptake of Gal-emulsions having Gal-C4-Chol of 4, 6, and 9% was inhibited suggesting asialoglycoprotein receptor mediated uptake. Moreover, Gal-emulsions having Gal-C4-Chol of 4, 6, and 9% showed a slight increase in surface binding and exhibited extensive uptake and internalization into HepG2 cells. The present study strongly suggested that the Gal-emulsions are taken up by the asialoglycoprotein receptor-mediated endocytosis and galactose density of Gal-emulsions is important for effective recognition and cell internalization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076536     DOI: 10.1016/j.ijpharm.2005.05.020

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line.

Authors:  Swati A Guhagarkar; Sharmila B Majee; Abdul Samad; Padma V Devarajan
Journal:  Cancer Nanotechnol       Date:  2011-01-27

Review 2.  Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems.

Authors:  Jing-Jun Yan; Jia-Zhi Liao; Ju-Sheng Lin; Xing-Xing He
Journal:  Tumour Biol       Date:  2014-11-26

Review 3.  Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma.

Authors:  Min Li; Weiyue Zhang; Birong Wang; Yang Gao; Zifang Song; Qi Chang Zheng
Journal:  Int J Nanomedicine       Date:  2016-10-31

4.  Mechanism of hepatic targeting via oral administration of DSPE-PEG-cholic acid-modified nanoliposomes.

Authors:  Ying Li; Chunyan Zhu
Journal:  Int J Nanomedicine       Date:  2017-02-28

5.  5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model.

Authors:  Mingrong Cheng; Bing He; Tao Wan; Weiping Zhu; Jiang Han; Bingbing Zha; Houxiang Chen; Fengxiao Yang; Qing Li; Wei Wang; Hongzhi Xu; Tao Ye
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

6.  Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma.

Authors:  Xiaoju Zhou; Mengzi Zhang; Bryant Yung; Hong Li; Chenguang Zhou; L James Lee; Robert J Lee
Journal:  Int J Nanomedicine       Date:  2012-10-16

7.  Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery.

Authors:  Yangming Guo; Xing Liu; Xun Sun; Qiang Zhang; Tao Gong; Zhirong Zhang
Journal:  Theranostics       Date:  2012-11-19       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.